The safety and efficacy of two celloid iron supplements in young women with mild anaemia.

Phase 3

• Conditions: Mild anemia; Blood - Anaemia

• Registration Number: ACTRN12605000632695
• Lead Sponsor: Blackmores Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-10-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 20

Inclusion Criteria

Good general health. Haemoglobin levels 10-12g/dl. Serum ferritin <20mg/L. Non-smoker.

Exclusion Criteria

Use of iron supplements 4 weeks before recruitment Liver function enzymes >3 times the upper limit of normal at baseline Hemochromatosis Polycythemia Sickle cell anaemia Gastro intestinal disorders Heart disease Taking oral anticoagulants Past allergic responses to iron supplementation Pregnancy or breast feeding Menorrhagia Consumption of more than 14 standard alcoholic drinks per week Conditions that compromise digestion or absorption of iron Taking antibiotics Taking zinc supplements Individuals who have had a gastrectomy Peptic or gastric ulcer Renal disease Affective disorders Subjects unwilling to comply with study protocol Poor venous access Any other condition, which in the opinion of the investigators could compromise the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified